Agios Pharmaceuticals (AGIO)
NASDAQ:AGIO
Want to see AGIO full AI Analyst Report?
Agios Pharma (AGIO) Ownership Overview
1.15% Insiders
26.35% Mutual Funds
51.63% Other Institutional Investors
19.76% ETFs
1.12% Public Companies and
Individual Investors
The ownership structure of Agios Pharma (AGIO) stock is a mix of institutional, retail, and individual investors. Approximately 97.73% of the company’s stock is owned by Institutional Investors, 1.15% is owned by Insiders, and 1.12% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Mar 05, 2026 | xxxxxxxxxxxxx | $152255 | |
Sep 09, 2025 | xxxxxxxxxxxxx | $315091 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Mar 31, 2024 | xxxxxxxxxxxxx | $192289720 | |
Mar 31, 2024 | xxxxxxxxxxxxx | $20732716 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,684,000 | Institution | 9.56% | 215,423,600 | |
| 5,179,577 | Institution | 8.71% | 196,305,968 | |
| 4,635,455 | Institution | 7.79% | 175,683,745 | |
| 4,013,671 | Institution | 6.75% | 152,118,131 | |
| 2,558,653 | Institution | 4.30% | 96,972,949 | |
| 2,155,827 | Institution | 3.62% | 81,705,843 | |
| 870,145 | Institution | 1.46% | 32,978,496 | |
| 647,405 | Institution | 1.09% | 24,536,650 | |
| 636,840 | Institution | 1.07% | 24,136,236 | |
| 628,221 | Institution | 1.06% | 23,809,576 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,635,455 | Institution | 7.79% | 175,683,745 | |
| 4,013,671 | Institution | 6.75% | 152,118,131 | |
| 647,405 | Institution | 1.09% | 24,536,650 | |
| 636,840 | Institution | 1.07% | 24,136,236 | |
| 609,500 | Institution | 1.02% | 23,100,050 | |
| 607,394 | Institution | 1.02% | 23,020,233 | |
| 602,777 | Institution | 1.01% | 22,845,248 | |
| 503,935 | Institution | 0.85% | 19,099,137 | |
| 373,695 | Institution | 0.63% | 14,163,041 | |
| 325,991 | Institution | 0.55% | 12,355,059 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,021,559 | Institution | 3.40% | 71,947,285 | |
| 1,889,471 | Institution | 3.18% | 55,550,447 | |
| 1,350,774 | Institution | 2.27% | 39,712,756 | |
| 1,318,792 | Institution | 2.22% | 47,845,774 | |
| 757,261 | Institution | 1.27% | 22,263,473 | |
| 663,318 | Institution | 1.12% | 19,501,549 | |
| 490,935 | Institution | 0.83% | 17,811,122 | |
| 388,019 | Institution | 0.65% | 14,077,329 | |
| 290,173 | Institution | 0.49% | 8,531,086 | |
| 280,614 | Institution | 0.47% | 9,987,052 |
FAQ
Who Owns Agios Pharmaceuticals (AGIO)?
According to the latest TipRanks data, approximately 51.63% of the company's stock is held by institutional investors, 1.15% is held by insiders, and 1.12% is held by retail investors.
What percentage of Agios Pharmaceuticals (AGIO) stock is held by institutional investors?
According to the latest TipRanks data, approximately 51.63% of Agios Pharmaceuticals (AGIO) stock is held by institutional investors.
What percentage of Agios Pharmaceuticals (AGIO) stock is held by retail investors?
According to the latest TipRanks data, approximately 1.12% of Agios Pharmaceuticals (AGIO) stock is held by retail investors.
Who owns the most shares of Agios Pharmaceuticals (AGIO)?
Andrew J.M. Spokes owns the most shares of Agios Pharmaceuticals (AGIO).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.